Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|11|3|338-351

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.11, Iss.3, 2013-05, pp. : 338-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pleiotropic Effects of ARB in Diabetes Mellitus

By  

Current Vascular Pharmacology, Vol. 9, Iss. 2, 2011-03 ,pp. : 136-144

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

By Bajaj M.   Suraamornkul S.   Hardies L.   Glass L.   Musi N.   DeFronzo R.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1723-1731

Springer Publishing Company

Access to resources Recommend Favorite

Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus

By Nomura S.   Kanazawa S.   Fukuhara S.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 3, 2003-05 ,pp. : 153-159

Elsevier

Access to resources Recommend Favorite

Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance

By  

Current Diabetes Reviews, Vol. 9, Iss. 5, 2013-09 ,pp. : 412-417

Bentham Science Publishers

Access to resources Recommend Favorite

Incretins, insulin secretion and Type 2 diabetes mellitus

By Vilsbøll T.   Holst J.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 357-366

Springer Publishing Company

Access to resources Recommend Favorite